UA84453C2 - Применение производных метиленамида для лечения сердечно-сосудистых заболеваний - Google Patents

Применение производных метиленамида для лечения сердечно-сосудистых заболеваний

Info

Publication number
UA84453C2
UA84453C2 UAA200609879A UAA200609879A UA84453C2 UA 84453 C2 UA84453 C2 UA 84453C2 UA A200609879 A UAA200609879 A UA A200609879A UA A200609879 A UAA200609879 A UA A200609879A UA 84453 C2 UA84453 C2 UA 84453C2
Authority
UA
Ukraine
Prior art keywords
amide derivatives
cardiovascular disorders
methylene amide
prevention
formula
Prior art date
Application number
UAA200609879A
Other languages
English (en)
Ukrainian (uk)
Inventor
ван Хьойсдьойнен Роб Хофт
Венсен Рішар
Original Assignee
Эплайд Рисерч Системз Эрс Холдинг Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эплайд Рисерч Системз Эрс Холдинг Н.В. filed Critical Эплайд Рисерч Системз Эрс Холдинг Н.В.
Publication of UA84453C2 publication Critical patent/UA84453C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Это изобретение касается применения замещенных производных метиленамида формулы (І) для лечения и/или предупреждения сердечно-сосудистых заболеваний, например, обструкции коронарной артерии и сердечной недостаточности. В частности, это изобретение касается применения замещенных производных метиленамида формулы (І) для лечения и/или предупреждения эндотелиальной дисфункции при сердечной недостаточности. EMBED ISISServer (І)
UAA200609879A 2004-02-27 2005-02-25 Применение производных метиленамида для лечения сердечно-сосудистых заболеваний UA84453C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100778 2004-02-27
PCT/EP2005/050823 WO2005082347A1 (en) 2004-02-27 2005-02-25 Use of methylene amide derivatives in cardiovascular disorders

Publications (1)

Publication Number Publication Date
UA84453C2 true UA84453C2 (ru) 2008-10-27

Family

ID=34896106

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609879A UA84453C2 (ru) 2004-02-27 2005-02-25 Применение производных метиленамида для лечения сердечно-сосудистых заболеваний

Country Status (23)

Country Link
US (1) US20070185118A1 (ru)
EP (1) EP1732534B1 (ru)
JP (1) JP5001138B2 (ru)
KR (1) KR101188940B1 (ru)
CN (1) CN1933827B (ru)
AT (1) ATE401877T1 (ru)
AU (1) AU2005216649B2 (ru)
BR (1) BRPI0508080A (ru)
CA (1) CA2554919C (ru)
CY (1) CY1108252T1 (ru)
DE (1) DE602005008412D1 (ru)
DK (1) DK1732534T3 (ru)
EA (1) EA011811B1 (ru)
ES (1) ES2308458T3 (ru)
HR (1) HRP20080367T3 (ru)
IL (1) IL177494A (ru)
NO (1) NO20064295L (ru)
PL (1) PL1732534T3 (ru)
PT (1) PT1732534E (ru)
RS (1) RS50596B (ru)
SI (1) SI1732534T1 (ru)
UA (1) UA84453C2 (ru)
WO (1) WO2005082347A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE510817T1 (de) * 2002-01-29 2011-06-15 Merck Serono Sa Substituierte methylenamidderivate als modulatoren von proteintyrosinphosphatasen (ptps)
AU2004261400A1 (en) 2003-07-21 2005-02-10 Laboratoires Serono Sa Alkynyl aryl carboxamides
AU2007307599A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. N-phenyloxamic acid derivatives
US8633245B2 (en) * 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
JP2014525501A (ja) 2011-08-29 2014-09-29 ティコナ・エルエルシー 高流動性液晶ポリマー組成物
WO2013032967A1 (en) 2011-08-29 2013-03-07 Ticona Llc Cast molded parts formed form a liquid crystalline polymer
CN103764741B (zh) 2011-08-29 2015-09-23 提克纳有限责任公司 低熔体粘度液晶聚合物的熔融聚合
WO2013032977A1 (en) 2011-08-29 2013-03-07 Ticona Llc Heat-resistant liquid crystalline polymer composition having a low melting temperature
US8669341B2 (en) 2011-08-29 2014-03-11 Ticona Llc Solid-state polymerization of a liquid crystalline polymer
TW201319023A (zh) 2011-08-29 2013-05-16 Ticona Llc 具改良低剪切黏度之熱向性液晶聚合物
KR20140059825A (ko) 2011-08-29 2014-05-16 티코나 엘엘씨 고유동성 액정 중합체 조성물
CN103764623B (zh) 2011-08-29 2016-04-27 提克纳有限责任公司 芳族酰胺化合物
US8852730B2 (en) 2011-08-29 2014-10-07 Ticona Llc Melt-extruded substrate for use in thermoformed articles
WO2014095815A1 (en) 2012-12-17 2014-06-26 Shell Internationale Research Maatschappij B.V. Integrated gas-to-liquid condensate process
WO2014130275A2 (en) 2013-02-22 2014-08-28 Ticona Llc High performance polymer composition with improved flow properties
US9206300B2 (en) 2013-06-07 2015-12-08 Ticona Llc High strength thermotropic liquid crystalline polymer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019830A1 (en) * 1999-09-10 2001-03-22 Novo Nordisk A/S MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
US6627767B2 (en) * 2000-08-29 2003-09-30 Abbott Laboratories Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
DE10117823A1 (de) * 2001-04-10 2002-10-17 Merck Patent Gmbh Oxalsäurederivate
AR034374A1 (es) * 2001-06-07 2004-02-18 Wyeth Corp Combinacion de un inhibidor de ptpasa y un inhibidor de ace
WO2002098408A1 (en) * 2001-06-07 2002-12-12 Wyeth Ptpase inhibitors for improving cardiovascular risk profile
ATE510817T1 (de) * 2002-01-29 2011-06-15 Merck Serono Sa Substituierte methylenamidderivate als modulatoren von proteintyrosinphosphatasen (ptps)

Also Published As

Publication number Publication date
JP5001138B2 (ja) 2012-08-15
WO2005082347A1 (en) 2005-09-09
JP2007524701A (ja) 2007-08-30
AU2005216649B2 (en) 2010-09-09
HK1098073A1 (en) 2007-07-13
NO20064295L (no) 2006-09-22
KR20060129066A (ko) 2006-12-14
ATE401877T1 (de) 2008-08-15
RS50596B (sr) 2010-05-07
KR101188940B1 (ko) 2012-10-08
ES2308458T3 (es) 2008-12-01
EP1732534A1 (en) 2006-12-20
CN1933827B (zh) 2011-07-27
EA200601511A1 (ru) 2007-02-27
SI1732534T1 (sl) 2008-10-31
CA2554919C (en) 2013-04-16
IL177494A0 (en) 2006-12-31
EP1732534B1 (en) 2008-07-23
BRPI0508080A (pt) 2007-07-17
DK1732534T3 (da) 2008-11-17
IL177494A (en) 2011-06-30
PL1732534T3 (pl) 2008-12-31
CN1933827A (zh) 2007-03-21
HRP20080367T3 (en) 2008-09-30
PT1732534E (pt) 2008-08-08
CY1108252T1 (el) 2014-02-12
CA2554919A1 (en) 2005-09-09
DE602005008412D1 (de) 2008-09-04
US20070185118A1 (en) 2007-08-09
AU2005216649A1 (en) 2005-09-09
EA011811B1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
CY1108252T1 (el) Χρηση παραγωγων μεθυλενο αμιδης στις καρδιαγγειακες διαταραχες
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
WO2010030813A3 (en) Methods for inhibiting ocular angiogenesis
NZ548954A (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
TW200736253A (en) Pyridopyrazine derivatives and their use
WO2007075896A3 (en) Heterocyclic cytokine inhibitors
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
NO20091489L (no) Tiazolpyrazolopyridiner som CRF1 reseptorantagonister
DE602007012363D1 (de) 2,4-pyridimediamon-derivate als hemmer von jak-kinasen zur behandlung von autoimmunerkrankungen
MX2007002311A (es) Antagonistas del receptor de endotelina a(eta) en combinacion con inhibidores de fosfodiesterasa 5 (pdes) y usos de los mismos.
ATE553093T1 (de) Indazolderivate zur hemmung von trpv1 und verwendungen davon
ATE505191T1 (de) Ectoin zur behandlung von vascular leaks
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
WO2008034796A3 (en) Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
WO2005084654A3 (en) Methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
MA29246B1 (fr) Derives de dihydroimidazothiazole
MX2007011848A (es) Antagonistas del receptor de procineticina i.
TW200724140A (en) Hydantoin compounds
NO20073610L (no) Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
TW200621261A (en) Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
ATE547105T1 (de) Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems
TW200736264A (en) Thiazolo[4,5-C]pyridine derivatives